Cargando…
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
BACKGROUND: When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity and risk factors of the more severe COVID-19 cour...
Autores principales: | Stastna, Dominika, Menkyova, Ingrid, Drahota, Jiri, Mazouchova, Aneta, Adamkova, Jana, Ampapa, Radek, Grunermelova, Marketa, Peterka, Marek, Recmanova, Eva, Rockova, Petra, Rous, Matous, Stetkarova, Ivana, Valis, Martin, Vachova, Marta, Woznicova, Ivana, Horakova, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223114/ https://www.ncbi.nlm.nih.gov/pubmed/34216998 http://dx.doi.org/10.1016/j.msard.2021.103104 |
Ejemplares similares
-
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
por: Pavelek, Zbyšek, et al.
Publicado: (2021) -
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
por: Vališ, Martin, et al.
Publicado: (2022) -
Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)